Clinical Trials Logo
  1. Home
  2. Rituximab
  3. NCT05734794

Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial — STORM  

Nephrotic Syndrome in Children Clinical Trial

Official title:
Study of Rituximab Monotherapy VS Steroid Therapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial

Clinical Trial Summary

The main objective is to evaluate the effectiveness of Rituximab monotherapy versus steroid therapy on children with new-onset nephrotic syndrome within the 52-week follow-up.

Clinical Trial Description

Nephrotic syndrome(NS) -------the most common glomerular disease in children. Steroid, as the mainstream therapy for decades, many patients suffer from adverse effects of it, such as growth impacted, fat, and glaucoma.There is a urgent need for Steroid-sparing therapy. Rituximab, as a chemical monoclonal antibody against the cluster of differentiation antigen 20(CD20), has proved to be effective in patients with frequent-relapse/steroid-dependent NS. It has also been reported to be effective in six adult patients with new-onset NS. Rituximab mono-therapy in new-onset pediatric NS patients is still unclear. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05734794
Study type Interventional
Source The Children's Hospital of Zhejiang University School of Medicine
Contact Jianhua Mao, PHD.MD
Phone 86057186670015
Email maojh88@zju.edu.cn
Status Recruiting
Phase Phase 3
Start date February 9, 2023
Completion date July 30, 2026
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05044169 - Efficacy and Safety of Broncho-Vaxom in the First Episode of Pediatric Idiopathic Nephrotic Syndrome N/A
Recruiting NCT05588063 - taVNS for FRNS in Children N/A
Recruiting NCT05583942 - A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS) N/A
Recruiting NCT06125405 - Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome Phase 3
Completed NCT04034316 - Reduce Immunosuppression With Atmp in NS ChildrEn Phase 2
Completed NCT04048161 - Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome Phase 4
Recruiting NCT06079788 - Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial. Phase 3
Enrolling by invitation NCT04571658 - NEPTUNE Match Study
Recruiting NCT06417320 - Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years Phase 4
Recruiting NCT05843968 - Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome Phase 2
Not yet recruiting NCT06130631 - Predictors of Steroid Response in Childhood Nephrotic Syndrome
Terminated NCT03878914 - Steroid Sensitive Nephrotic Syndrome in Children Phase 4
Recruiting NCT03786263 - CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study
Recruiting NCT05772871 - The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children Phase 4
Recruiting NCT05505500 - Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.